GlassScriptPhysician profile
Chrystal Bradley
NPI 1366886392
$634.78
in general payments reported to CMS, 2019-2025
13 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.64 · 2020: $13.24 · 2021: $120 · 2022: $145 · 2023: $72.36 · 2024: $88.77 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $312.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $165.16 | 2019-2023 | Injectafer |
| Astellas Pharma US INC | $93.80 | 2024-2025 | Veozah |
| Sage Therapeutics, LLC | $79.00 | 2024-2025 | Zurzuvae |
| Roche Diagnostics Corporation | $52.70 | 2021 | |
| Organon LLC | $38.80 | 2022-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $38.57 | 2021 | |
| Intuitive Surgical, INC. | $28.98 | 2023 | Da Vinci Surgical System |
| Teleflex LLC | $28.56 | 2021 | |
| Sumitomo Pharma America, INC. | $26.34 | 2025 | Myfembree |
| Merck Sharp & Dohme LLC | $26.11 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $20.26 | 2025 | Qelbree |
| Baxter Healthcare | $20.08 | 2019 | |
| Lsi Solutions INC | $16.42 | 2023 | Fornisee |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chrystal Bradley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.